Decoding Perioperative Immunotherapy In NSCLC
Listen now
Description
In this TOGA podcast, we provide an overview of the recent neoadjuvant, adjuvant, and perioperative IO data, the options and considerations for treatment and the current reimbursement landscape. Dr Pei Ni Ding, Medical Oncologist from Westmead and Nepean Hospitals Sydney, is joined by Dr Samantha Bowyer, Medical Oncologist from Sir Charles Gairdner Hospital in Perth and Mr Naveed Alam, Thoracic Surgeon from St Vincents, Epworth and Monash in Melbourne. Many emerging treatments are discussed in this podcast, and clinicians are reminded that oncology access programs are listed in the medicines access portal https://www.medicinesap.com/
More Episodes
In this episode, we dive into the latest survival data from the ADRIATIC trial, as presented at ASCO 2024, which could change the treatment landscape for LS-SCLC. Joining us are leading experts in oncology Zarnie Lwin, Susan Harden and Wei-Sen Lam. Together, they explore the significance of the...
Published 09/30/24
Published 09/30/24
In this TOGA podcast, we provide an overview of the treatment options for rare subtypes of oncogene driven NSCLC that are now readily identified in the MBS-reimbursed small gene panel including NTRK1, 2,3 and other rare mutations in NSCLC. The importance of testing all patients is discussed as...
Published 08/30/24